defunct biotechnology companies: mergers and acquisitions, business liquidation, insolvency, renaming

Defunct Biotechnology Companies

Magainin Pharmaceutcals, Inc.	renamed	Genaera Corporation	2001
Marathon Biopharmaceuticals, LLC	acquired by	Cambrex Corporation	2001
Matrigen, Inc.	merged to	Selective Genetics, Inc.	1998
Maxia Pharmaceuticals, Inc.	acquired by	Incyte Genomics, Inc.	2003
MDIS Publications	renamed	Espicom Business Intelligence	1998
MDS Proteomics, Inc.	renamed	Protana, Inc.	2004
Medigene Oy	renamed	Oy Quattrogene Ltd.	2000
metaGen Pharmaceuticals GmbH	acquired by	Astex Technology Ltd.	2003
Metaphore Pharmaceuticals; Inc.	acquired by	ActvBiotics, Inc.	2006
Modex Therapeutiques SA	merged	IsoTis SA	2002
Molecular Applications Group	acquired by	Celera	1999
Molecular Light Technology Ltd.	acquired by	Gen-Probe Corp.	2003
Molecular Probes, Inc.	acquired by	Invitrogen Corp.	2003
Molecular Tool, Inc.	acquired by	Orchid Biocomputer, Inc.	1998
Mycometrix Corp.	renamed	Fluidigm Corp.	2001